This HTML5 document contains 121 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
n8http://dx.doi.org/10.1158/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n12http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q46365780
rdf:type
wikibase:Item
schema:description
2005年学术文章 artikulong pang-agham bilimsel makale artículu científicu article scientifique (publié 2005) 2005年學術文章 مقالهٔ علمی 2005年学术文章 2005年學術文章 мақолаи илмӣ مقالة علمية ২০০৫-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ mokslinis straipsnis articolo scientifico 2005年学术文章 vitenskapelig artikkel artigo científico (publicado na 2005) 2005年學術文章 научная статья teaduslik artikkel scientific article 2005年の論文 vědecký článek videnskabelig artikel (udgivet 2005) artikull shkencor artykuł naukowy wetenschappelijk artikel 2005年學術文章 artigo científico (publicado na 2005) מאמר מדעי научни чланак articol științific سائنسی مضمون naučni članak vitskapeleg artikkel мақолаи илмӣ bài báo khoa học 2005 nî lūn-bûn vetenskaplig artikel artigo científico 2005年學術文章 artículo científico publicado en 2005 научна статия wissenschaftlicher Artikel article científic article scientific научни чланак บทความทางวิทยาศาสตร์ 2005年学术文章 2005年學術文章 2005年学术文章 επιστημονικό άρθρο наукова стаття, опублікована в березні 2005 სამეცნიერო სტატია tieteellinen artikkeli vedecký článok tudományos cikk scienca artikolo գիտական հոդված 2005년 논문
p:P577
wds:Q46365780-B1DC5355-FFDC-4F6F-B42D-B3CCD30B0268
wdt:P577
2005-03-01T00:00:00Z
p:P407
wds:Q46365780-E182332E-EF54-4043-8F66-D43C4F70D64B
wdt:P407
wd:Q1860
p:P2093
wds:Q46365780-0672A8AA-0485-413B-BA3C-8A0A201C09E7 wds:Q46365780-1EBA2750-E272-4EDB-A95E-CC0AF793D8E8 wds:Q46365780-0DFC0DBD-738C-44CA-8E51-2C24B45A0911 wds:Q46365780-65521CC1-B40E-4CC6-A2D8-97C8862167EE wds:Q46365780-796904C3-BE45-46EF-9388-6E7DE533755E wds:Q46365780-9AE700BD-D0E5-453E-BFCD-7C4FF53C3E6C wds:Q46365780-ABA1432D-1E25-42B5-88EA-3695EBD4B070 wds:Q46365780-A6F06B20-6567-4356-A5E9-545CEB6BE93C wds:Q46365780-CAEC5E27-5820-414D-B9D0-25450E7EC70D wds:Q46365780-B71213D2-6380-4B94-81C3-FB44B5A9E78D wds:Q46365780-FF71B61D-A5B9-401F-96EC-D64E42D03360
wdt:P2093
Joseph Arezzo Michael Michael Michael Daly Michael Green Michael Chia Leonie Harrison Lachlan MacGregor Mark Rosenthal Peter Bartley Lynette Kiers Ian D Davis
rdfs:label
A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy.
skos:prefLabel
A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy. A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy
schema:name
A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy. A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy
p:P50
wds:Q46365780-5A18C1CB-CEE1-40FC-B134-624A5C325BBC
wdt:P50
wd:Q40172411
p:P1476
wds:Q46365780-1E0F7094-7A43-43A9-A37C-03CA909B4286
wdt:P1476
A randomized, double-blinded, placebo-controlled phase II trial of recombinant human leukemia inhibitory factor (rhuLIF, emfilermin, AM424) to prevent chemotherapy-induced peripheral neuropathy.
p:P304
wds:Q46365780-CD9D343F-C991-4C8A-BE10-ACD6C3BE0B24
wdt:P304
1890-1898
p:P31
wds:Q46365780-AA6AFD3C-ABA9-4099-9412-1E24576DE16F
wdt:P31
wd:Q13442814
p:P921
wds:Q46365780-C2E1DFA7-0F7F-419A-B471-CE85F9F9598D wds:Q46365780-E134A389-4676-495A-A82F-1383CE1FA65F wds:Q46365780-7B01F07D-F3CB-4F14-B164-DE382D7A96D4 wds:Q46365780-7B58428C-496D-4362-9B6F-CC4C3369622B
wdt:P921
wd:Q269829 wd:Q974135 wd:Q42824440 wd:Q29496
p:P698
wds:Q46365780-E57C3974-7509-4D77-8954-021214624881
wdtn:P698
n12:15756015
wdt:P698
15756015
p:P1433
wds:Q46365780-A1F0D36E-2FDB-44CB-96A5-9E3947B75B7D
wdt:P1433
wd:Q332253
p:P433
wds:Q46365780-19004492-D606-435D-A766-23804D44FDC2
p:P478
wds:Q46365780-040723A3-8D0A-486F-8746-CBAEBE094F73
wdt:P433
5
wdt:P478
11
p:P356
wds:Q46365780-5B4E099C-C580-432A-9DC7-2A9DD7B1130E
wdtn:P356
n8:1078-0432.CCR-04-1655
wdt:P356
10.1158/1078-0432.CCR-04-1655